• 1. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Halohydrins Chlorohydrins

Professional Introduction to (S)-1-Chloro-2-propanol (CAS No. 37493-16-6)

Compound (S)-1-Chloro-2-propanol, identified by the Chemical Abstracts Service Number (CAS No.) 37493-16-6, is a significant chiral intermediate in the field of pharmaceutical and chemical synthesis. This compound, characterized by its specific stereochemistry, has garnered considerable attention due to its utility in the development of various biologically active molecules. The enantiomeric purity and structural integrity of (S)-1-Chloro-2-propanol are critical factors that influence its applicability in synthetic pathways and drug design.

The molecular structure of (S)-1-Chloro-2-propanol consists of a propanol backbone with a chlorine substituent at the first carbon position, imparting unique reactivity and functional properties. The (S) configuration denotes the spatial arrangement of atoms around the chiral center, which is pivotal for achieving enantioselective synthesis. This stereochemical specification makes it a valuable building block in the synthesis of optically active compounds, particularly in the pharmaceutical industry where chirality often dictates the efficacy and safety of a drug.

In recent years, advancements in asymmetric synthesis have highlighted the importance of chiral auxiliaries and catalysts in enhancing the yield and selectivity of enantioenriched intermediates like (S)-1-Chloro-2-propanol. Current research trends indicate that transition metal-catalyzed reactions, such as those involving palladium or rhodium complexes, have shown promise in facilitating the stereoselective transformation of prochiral substrates. These methodologies not only improve the efficiency of synthetic routes but also reduce environmental impact by minimizing waste and energy consumption.

The pharmaceutical applications of (S)-1-Chloro-2-propanol are extensive, with its role as a precursor in the synthesis of various therapeutic agents being well-documented. For instance, it has been utilized in the preparation of β-blockers, which are widely used to treat cardiovascular conditions such as hypertension and angina pectoris. Additionally, its incorporation into pharmacophores has been explored in the development of novel antimicrobial agents, addressing the growing challenge of antibiotic resistance. The compound's ability to serve as a chiral synthon allows for the construction of complex molecular architectures with high precision.

Recent studies have also delved into the biochemical pathways where (S)-1-Chloro-2-propanol participates as an intermediate or modulator. Research indicates that derivatives of this compound may exhibit inhibitory effects on specific enzymes or receptors, making them potential candidates for therapeutic intervention. For example, modifications to the chlorine substituent or the hydroxyl group have been investigated to optimize binding affinity and metabolic stability. Such structural elucidations contribute to a deeper understanding of drug-receptor interactions and aid in rational drug design.

The industrial production of (S)-1-Chloro-2-propanol involves meticulous process optimization to ensure high enantiomeric excess and minimal byproduct formation. Continuous flow chemistry has emerged as a promising approach for scaling up chiral synthesis while maintaining high purity standards. This technology offers advantages such as improved reproducibility, reduced solvent usage, and enhanced safety profiles compared to traditional batch processing methods. The integration of flow chemistry with biocatalysis further underscores the shift towards greener synthetic methodologies.

In conclusion, (S)-1-Chloro-2-propanol (CAS No. 37493-16-6) represents a cornerstone in modern synthetic chemistry and pharmaceutical research. Its unique stereochemical properties and versatile reactivity make it indispensable in constructing complex molecules with therapeutic potential. As research continues to uncover new applications and synthetic strategies, this compound will undoubtedly remain at the forefront of innovation in medicinal chemistry and chemical biology.

• 60827-45-4((S)-3-Chloro-1,2-propanediol)
• 57090-45-6((R)-(-)-3-Chloro-1,2-propanediol)
• 19141-39-0((R)-1-Chloro-2-propanol)
• 27988-86-9(1,3-dichloropropan-2-ol)
• 1873-25-2(1-chlorobutan-2-ol)
• 558-42-9(1-Chloro-2-methyl-2-propanol)
• 312745-09-8(Gold, [m-[1,2-ethanediylbis[diphenylphosphine-kP]]][m-[1,2-phenylenebis(oxy-1-propyne-3,1-diyl)]]di- (9CI))
• 110053-43-5(Imidodicarbonic diamide, N,N,2-tris(6-isocyanatohexyl)-, reaction products with 3-chloro-1,2-propanediol and alpha-fluoro-omega-(2-hydroxyethyl)poly(difluoromethylene))
• 1173020-20-6(1,3-Dichloro-2-propanol-d5)
• 342611-01-2(3-Chloro-1,2-propanediol-d5)